No association between enterovirus 71 (EV71) vaccination and risk of febrile seizures: a population-based near real-time surveillance study

References

• Ooi MH, Wong SC, Lewthwaite P, et al. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9(11):1097–1105.
   PubMed Web of Science ®Google Scholar
• Zhu FC, Meng FY, Li JX, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381(9882):2024–2032.
   PubMed Web of Science ®Google Scholar
• Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778–790.
   PubMed Web of Science ®Google Scholar
• Li R, Liu L, Mo Z, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370(9):829–837.
   PubMed Web of Science ®Google Scholar
• Zhu F, Xu W, Xia J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370(9):818–828.
   PubMed Web of Science ®Google Scholar
• Moro PL, Haber P, McNeil MM. Challenges in evaluating post-licensure vaccine safety: observations from the centers for disease control and prevention. Expert Rev Vaccines. 2019;18(10):1091–1101.
   PubMed Web of Science ®Google Scholar
• Crawford NW, Clothier H, Hodgson K, et al. Active surveillance for adverse events following immunization. Expert Rev Vaccines. 2014;13(2):265–276.
   PubMed Web of Science ®Google Scholar
• Liu DW, Wu WD, Li KL, et al. Surveillance of adverse events following immunization in China: past, present, and future. Vaccine. 2015;33(32):4041–4046.
   PubMed Web of Science ®Google Scholar
• Disha X, Keli L, Wendi W, et al. Adverse events following immunization in China, 2016. Chin J Vaccines Immunization. 2018;24(3):299–309+322.
   Google Scholar
• Keli L, Lina Z, Jiakai Y, et al. Surveillance of adverse events following immunization in China, 2017. Chin J Vaccines Immunization. 2020;26(1):9–18.
   Google Scholar
• Lina Z, Keli L, Wen D, et al. Surveillance of adverse events following immunization in China, 2018. Chin J Vaccines Immunization. 2020;26(4):363–371.
   Google Scholar
• Davis RL. Vaccine safety surveillance systems: critical elements and lessons learned in the development of the US Vaccine Safety Datalink’s rapid cycle analysis capabilities. Pharmaceutics. 2013;5(1):168–178.
   PubMedGoogle Scholar
• Greene SK, Kulldorff M, Lewis EM, et al. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. Am J Epidemiol. 2010;171(2):177–188.
   PubMed Web of Science ®Google Scholar
• Mesfin YM, Cheng A, Lawrie J, et al. Use of routinely collected electronic healthcare data for postlicensure vaccine safety signal detection: a systematic review. BMJ Glob Health. 2019;4(4):e001065.
   PubMedGoogle Scholar
• Leite A, Andrews NJ, Thomas SL. Near real-time vaccine safety surveillance using electronic health records-a systematic review of the application of statistical methods. Pharmacoepidemiol Drug Saf. 2016;25(3):225–237.
   PubMedGoogle Scholar
• Davis RL, Kolczak M, Lewis E, et al. Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology. 2005;16(3):336–341.
   PubMedGoogle Scholar
• Donahue JG, Kieke BA, Lewis EM, et al. Near real-time surveillance to assess the safety of the 9-valent human papillomavirus vaccine. Pediatrics. 2019;144(6):e20191808.
   PubMedGoogle Scholar
• Weintraub ES, Baggs J, Duffy J, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med. 2014;370(6):513–519.
   PubMed Web of Science ®Google Scholar
• Leite A, Thomas SL, Andrews NJ. Implementing near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD). Vaccine. 2017;35(49Pt B):6885–6892.
   PubMedGoogle Scholar
• Zhang L, Wang H, Li Q, et al. Big data and medical research in China. BMJ. 2018;360:j5910.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhang L, Yang Y, et al. Active surveillance of adverse events following human papillomavirus vaccination: feasibility pilot study based on the regional health care information platform in the city of Ningbo, China. J Med Internet Res. 2020;22(6):e17446.
   PubMed Web of Science ®Google Scholar
• Xu L, Li N, Zhang L, et al. Febrile seizures and measles-containing vaccines in China: a self-controlled case series study. Vaccines (Basel). 2021;9(10):1073.
   PubMed Web of Science ®Google Scholar
• Wei M, Meng F, Wang S, et al. 2-year efficacy, immunogenicity, and safety of Vigoo enterovirus 71 vaccine in healthy Chinese children: a randomized open-label study. J Infect Dis. 2017;215(1):56–63.
   PubMed Web of Science ®Google Scholar
• Macartney K, Gidding HF, Trinh L, et al. Evaluation of combination measles-mumps-rubella-varicella vaccine introduction in Australia. JAMA Pediatr. 2017;171(10):992–998.
   PubMed Web of Science ®Google Scholar
• Lee GM, Greene SK, Weintraub ES, et al. H1N1 and seasonal influenza vaccine safety in the Vaccine Safety Datalink project. Am J Prev Med. 2011;41(2):121–128.
   PubMed Web of Science ®Google Scholar
• Rowhani-Rahbar A, Klein NP, Dekker CL, et al. Biologically plausible and evidence-based risk intervals in immunization safety research. Vaccine. 2012;31(1):271–277.
   PubMedGoogle Scholar
• Nelson JC, Yu O, Dominguez-Islas CP, et al. Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. Am J Epidemiol. 2013;177(2):131–141.
   PubMedGoogle Scholar
• Tse A, Tseng HF, Greene SK, et al. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. Vaccine. 2012;30(11):2024–2031.
   PubMed Web of Science ®Google Scholar
• Li R, Stewart B, McNeil MM, et al. Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons. Pharmacoepidemiol Drug Saf. 2016;25(8):928–934.
   PubMedGoogle Scholar
• Kulldorff M, Davis RL, Kolczak M, et al. A maximized sequential probability ratio test for drug and vaccine safety surveillance. Sequential Anal. 2011;30(1):58–78.
   Web of Science ®Google Scholar
• Li L, Kulldorff M. A conditional maximized sequential probability ratio test for pharmacovigilance. Stat Med. 2010;29(2):284–295.
   PubMedGoogle Scholar
• IR S, M. K. Sequential: exact sequential analysis for poisson and binomial data. R Package Version 3.3.1. 2021 Accessed11 October 2021. Available from: http://CRAN.R-project.org/package=Sequential
   Google Scholar
• Yih WK, Kulldorff M, Fireman BH, et al. Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project. Pediatrics. 2011;127(Suppl 1):S54–64.
   PubMedGoogle Scholar
• Patel N, Ram D, Swiderska N, et al. Febrile seizures. BMJ. 2015;351:h4240.
   PubMedGoogle Scholar
• Chung B, Wat LC, Wong V. Febrile seizures in southern Chinese children: incidence and recurrence. Pediatr Neurol. 2006;34(2):121–126.
   PubMedGoogle Scholar
• Sammon CJ, Charlton RA, Snowball J, et al. The incidence of childhood and adolescent seizures in the UK from 1999 to 2011: a retrospective cohort study using the clinical practice research datalink. Vaccine. 2015;33(51):7364–7369.
   PubMedGoogle Scholar
• Principi N, Esposito S. Vaccines and febrile seizures. Expert Rev Vaccines. 2013;12(8):885–892.
   PubMed Web of Science ®Google Scholar
• Klein NP, Fireman B, Yih WK, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics. 2010;126(1):e1–e8.
   PubMed Web of Science ®Google Scholar
• Li X, Lin Y, Yao G, et al. The influence of vaccine on febrile seizure. Curr Neuropharmacol. 2018;16(1):59–65.
   PubMedGoogle Scholar
• Verbeek NE, Jansen FE, Vermeer-de Bondt PE, et al. Etiologies for seizures around the time of vaccination. Pediatrics. 2014;134(4):658–666.
   PubMed Web of Science ®Google Scholar
• Petersen I, Douglas I, Whitaker H. Self controlled case series methods: an alternative to standard epidemiological study designs. BMJ. 2016;354:i4515.
   PubMed Web of Science ®Google Scholar
• Yoon D, Lee JH, Lee H, et al. Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study. BMJ. 2021;372:m4931.
   PubMedGoogle Scholar
• Baggs J, Gee J, Lewis E, et al. The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics. 2011;127(Suppl 1):S45–53.
   PubMed Web of Science ®Google Scholar
• Leite A, Thomas SL, Andrews NJ. Do delays in data availability limit the implementation of near real-time vaccine safety surveillance using the clinical practice research datalink? Pharmacoepidemiol Drug Saf. 2018;27(1):25–29.
   PubMedGoogle Scholar
• Nelson JC, Cook AJ, Yu O, et al. Methods for observational post-licensure medical product safety surveillance. Stat Methods Med Res. 2015;24(2):177–193.
   PubMedGoogle Scholar
• Liu Z, Meng R, Yang Y, et al. Active vaccine safety surveillance: global trends and challenges in China. Health Data Sci. 2021;2021:10.
   Google Scholar